Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

2022 Nelson's Pediatric Antimicrobial Therapy, PDF eBook

2022 Nelson's Pediatric Antimicrobial Therapy PDF

Edited by John S. Bradley, John D. Nelson

PDF

Please note: eBooks can only be purchased with a UK issued credit card and all our eBooks (ePub and PDF) are DRM protected.

Description

Completely updated and revised, the 28th edition of this best-selling reference provides instant access to the latest recommendations for treatment of infectious diseases in children.

For each disease, the authors provide a commentary to help select the best of all antimicrobial choices. Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens.

TOPICS INCLUDE

  • Antimicrobial Therapy by Clinical Syndromes
  • Antimicrobial Therapy for Neonates
  • Choosing Among
    • Antibiotics
    • Antifungal Agents
    • Antiviral Agents
    • Antiparasitic Agents
  • Oral Step-down Therapy for Serious Infections
  • Prevention of Symptomatic Infection
  • Approach to Antibiotic Allergies
  • Antibiotic Stewardship
New in the 28th Edition
  • Updated recommendations on acute hematogenous osteomyelitis, based on newly published guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America, including information on a decrease in the incidence of MRSA infections, allowing the recommendation of cefazolin, again, in empiric therapy for most pediatric bone infections
  • Updated recommendations on influenza treatment and prophylaxis, reflecting American Academy of Pediatrics guidance for 20212022
  • Ceftazidime/avibactam now preferred over fluoroquinolones for treatment of Klebsiella pneumoniae carbapenemaseproducing enteric bacilli, if susceptible
  • Cefiderocol, a new iron-binding siderophore cephalosporin class, recently approved in adults for treatment of many drug-resistant pathogens, particularly Acinetobacter, Stenotrophomonas, and Pseudomonas; under study in children
  • New dosing for posaconazole suspension formulation
  • New approaches to mucormycosis
  • Added baloxavir for children 12+ years old
  • Online updates of COVID-19 therapies once emergency use authorization in children at http://www.aap.org/nelsons
  • Updated Nelson's app also available







Information

Information